ARLINGTON, VA, June 10, 2002 -- The National Asthma Education and Prevention Program (NAEPP), has issued an update of selected topics in the Guidelines for the Diagnosis and Management of Asthma. The guidelines now recommend inhaled corticosteroids as safe, effective and preferred first-line therapy for children as well as adults with persistent asthma. The update continues to recommend a "step-wise" approach to asthma management -- in which treatment is adjusted depending on disease severity -- but it modifies specific treatment recommendations at each step to reflect research over the last five years.

Coordinated by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, NAEPP convenes an expert panel as needed to ensure that the asthma guidelines reflect the latest scientific advances. The guidelines were first published in 1991 and revised in 1997. An Executive Summary of the update report was released today at the NAEPP Coordinating Committee meeting. This is the first in a series of periodic revisions on selected topics, making the guidelines a dynamic resource for clinicians.

"NHLBI is committed to ensuring that asthma patients benefit from the latest research findings," said NHLBI Director Dr. Claude Lenfant. "Asthma is one of the most common chronic health conditions in the United States, and the number of Americans who suffer from asthma continues to rise. It is essential that they are treated according to the best available scientific evidence, and this update brings such evidence to clinical practice."

The update stresses that inhaled corticosteroids are preferred for controlling and preventing asthma symptoms, and for improving lung function and quality of life. Inhaled steroids treat chronic inflammation of the airways, which has been confirmed as a key characteristic of asthma.

"We have learned a lot about the effectiveness and safety of inhaled steroids in the past few yea
'"/>

Contact: NHLBI Communications Office
301-496 - 4236
NIH/National Heart, Lung, and Blood Institute
10-Jun-2002

Page: 1 2 3
Related medicine news :

1. CDC: Update on current influenza season and vaccine supply in the United States
2. Updated adjuvant data presented at SABCS show 30 percent reduction in recurrence
3. Updated press release to October 2004 Cochrane Review
4. Update on cholesterol guidelines: more-intensive treatment options for higher risk patients
5. Update: Third International Conference on Cancer and the Adolescent
6. Updated data compares DOXIL (R)/CAELYX (TM) (doxorubicin HCl liposome injection) to Topotecan
7. Update on CDC outbreak investigation
8. Newly Updated HIV Treatment Guidelines For Adults And Adolescents Available On The World Wide Web
9. Updated Results On Heart Assist Device Presented At International Transplant Meeting
10. UIC professor receives international humanitarian award
11. International breast cancer prevention study launches in the United States and Canada